Liver Cancer

News Liver Cancer

• Possible new therapy for the treatment of a common blood cancer

  Research from Karolinska Institutet in Sweden shows that sorafenib, a drug used for advanced cancer of the kidneys and liver, could also be effective against multiple myeloma. The disease is one of the more common forms of blood cancer and is generally incurable. “Recently developed drugs, like bort more

• Hepatitis C virus hijacks liver microRNA

  Viral diseases are still one of the biggest challenges to medical science. Thanks to thousands of years of co-evolution with humans, their ability to harness the biology of their human hosts to survive and thrive makes them very difficult to target with medical treatment.Scientists at the University more

• After a good third quarter: Bayer confirms Group outlook

  The Bayer Group achieved further sales growth and significantly increased earnings in the third quarter of 2011. “It was a good quarter for Bayer,” Management Board Chairman Dr. Marijn Dekkers said Thursday at the presentation of the interim report. He described the continuing growth momentum in the more

Publications Liver Cancer

• Metabolomics for tumor marker discovery and identification based on chromatography–mass spectrometry

  Early detection is the most effective way to improve the clinical outcome of malignancies. Although some tumor markers are now widely used in the clinic, their sensitivity and specificity are still not satisfactory. Thus, there is an urgent requirement for the discovery of new tumor markers. By meas more

• Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance

  The hepatitis C virus (HCV) infects an estimated 150 million people worldwide and is the major cause of viral hepatitis, cirrhosis, and liver cancer. The available antiviral therapies, which include PEGylated interferon, ribavirin, and one of the HCV NS3/4A protease inhibitors telaprevir or boceprev more

• IL-1β Production through the NLRP3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection with Liver Inflammation and Disease

  by Amina A. Negash, Hilario J. Ramos, Nanette Crochet, Daryl T. Y. Lau, Brian Doehle, Neven Papic, Don A. Delker, Juandy Jo, Antonio Bertoletti, Curt H. Hagedorn, Michael Gale Chronic hepatitis C virus (HCV) infection is a leading cause of liver disease. Liver inflammation underlies infe more

Market studies Liver Cancer

• Liver Cancer – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Liver Cancer - Pipeline Review, Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H2 2012', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Cancer, complete with more

• Metastatic Liver Cancer – Pipeline Review, H2 2012

  Introduction Global Markets Direct’s, 'Metastatic Liver Cancer - Pipeline Review, H2 2012', provides an overview of the Metastatic Liver Cancer therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and speci more

• Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012

  Introduction GlobalData's clinical trial report, “Metastatic Liver Cancer Global Clinical Trials Review, H1, 2012" provides data on the Metastatic Liver Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Metastatic Liver Cancer. It more

Websites Liver Cancer